Across TCGA pan-cancer cohorts, ZNF544 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ZNF544 data layer compared with 23 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ZNF544 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF544 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LSCC show a favorable association.

LUAD and LSCC are the cancer types where ZNF544 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	II,III,IV	0.872	0.276	.004	15	view →
LSCC	OS	Median	All	1.000	0.894	.032	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ZNF544 tumor-vs-normal RNA expression · all ZNF544 data types